<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:mobile="http://www.google.com/schemas/sitemap-mobile/1.0" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
<url><loc>https://p3therapeutics.eu/news/tta-age-eic-pathfinder-application</loc><lastmod>2026-11-08T20:56:17.623Z</lastmod></url>
<url><loc>https://p3therapeutics.eu/news/gateway-eurostars-4-application</loc><lastmod>2026-11-08T20:56:16.446Z</lastmod></url>
<url><loc>https://p3therapeutics.eu/news/vesna-vc-backs-p3-therapeutics</loc><lastmod>2026-10-08T10:15:45.120Z</lastmod></url>
<url><loc>https://p3therapeutics.eu/news/investeu-support</loc><lastmod>2026-11-08T20:56:18.308Z</lastmod></url>
<url><loc>https://p3therapeutics.eu/news/six-tta-molecules-synthesised</loc><lastmod>2026-11-08T20:56:15.827Z</lastmod></url>
</urlset>